Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Convatec survey challenges assumptions about leakage in ostomy care

New global findings highlight the role of peristomal skin health in improving outcomes and confidence for people living with an ostomy

London, United Kingdom, 06 October 2026 – Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in Ostomy Care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routine care.

For many people, leakage is not only a clinical or product issue; it can shape whether they feel able to travel, exercise, socialise or take part fully in everyday life. More than half of respondents said they avoid such activities due to worry about their ostomy.

The results of the survey, which included more than 1,800 people living with an ostomy and over 400 healthcare professionals, point to a significant opportunity to improve outcomes through greater focus on peristomal skin health, the specific area of skin that surrounds a stoma, and more consistent, evidence‑based approaches to routine care.

Bruno Pinheiro, President, Ostomy Care, said: “For too long, leakage has been seen as an unavoidable part of life with an ostomy. This research challenges that view. It shows that less visible leakage and skin damage are closely connected, and that by focusing earlier on skin health, we have an opportunity to help people feel more secure, more confident and more in control of their daily lives.”  

The research builds on Convatec’s flagship research published in 2025, Perspectives on living with chronic conditions, which revealed that social stigma, rather than the physical condition itself, is the single biggest barrier for 1 in 3 people living with chronic illnesses, with approximately 13.5 million people worldwide living with a stoma1.

Leakage is more common and less visible than many realise
More than half of people living with an ostomy reported experiencing leakage in the past year. However, when asked specifically about under‑baseplate leakage, where waste is not always visible, nearly two thirds said they experienced it within the past month. The difference suggests that people don’t always recognise or describe under-baseplate leakage as a “leak”.

This gap highlights a disconnect between patient experience and how leakage is understood in practice, which means some of the most common issues in ostomy care may be under‑reported and under‑addressed. These “silent leaks” can undermine adhesion and contribute to skin irritation over time.

Skin health is central to breaking the leakage cycle
The findings highlight a recurring cycle in ostomy care: leakage exposes skin to moisture, damaged skin weakens adhesion, and poor adhesion increases the risk of further leakage.

Nearly four in ten respondents reported peristomal skin problems in the past 12 months, most commonly redness, soreness, or itching. While many people attribute these symptoms to adhesive sensitivity, healthcare professionals more often identified moisture exposure and an imperfect seal as key contributors.

This cycle demonstrates that addressing leakage in isolation is not enough. Improving outcomes requires a more holistic approach that prioritises protecting skin health as the foundation for reliable system performance, comfort and confidence.

Confidence is the real-world outcome that matters
Confidence influences how people manage their condition, engage in daily activities and maintain independence. Therefore, it should not be considered a secondary outcome in ostomy care, but one of the clearest measures of whether care is delivering meaningful, real‑world outcomes.

Convatec is committed to helping advance this shift by supporting clearer, more consistent and evidence-based approaches to peristomal skin health. Through initiatives such as Convatec’s me+ personalised support programme, Convatec is helping clinicians and people living with an ostomy better identify, prevent and address avoidable skin complications and ultimately help them feel more secure and confident in everyday life.

The full report, Rethinking leakage in Ostomy Care, is available here.

References
1. Hidden Disabilities Sunflower. Ostomy (2026). Available online at: https://hdsunflower.com/row/insights/post/ostomy (Accessed September 2026).

Contacts
Media:
mediarelations@convatec.com
Investor Relations:
IR@convatec.com

About the survey

This report is based on a 2026 online survey of 1,841 people living with an ostomy and 431 healthcare professionals across ten countries.

About Convatec
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec’s revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com.

Press Release

See all

06-Oct-26

Corporate

Ostomy Care

Convatec survey challenges assumptions about leakage in ostomy care

Convatec survey challenges assumptions about leakage in ostomy care

New global findings highlight the role of peristomal skin health

Read more Read more

28-Sep-26

Corporate

Continence Care

Cure Aqua™ launches in the United States and Canada

Convatec expands Cure™ portfolio with launch of Cure Aqua™, bringing greater ...

Cure Aqua™ launches in the United States and Canada

Read more Read more

27-Aug-26

Corporate

Non-Executive Director appointment

Non-Executive Director appointment

Dr Jens Viebke appointed as a Non-Executive Director, effective immediately.

Read more Read more

14-Aug-26

Corporate

Our People

Convatec appoints Dave Ubachs as Chief Digital & Information Officer

Convatec appoints Dave Ubachs as Chief Digital & Information Officer

Convatec announces the appointment of Chief Digital & Information Officer

Read more Read more

04-Aug-26

Corporate

Convatec commences share buyback programme

Convatec commences share buyback programme

Convatec will commence a non-discretionary share buyback programme

Read more Read more

04-Aug-26

Corporate

Financial Performance

Interim results for the six months ended 30 June 2026

Interim results for the six months ended 30 June 2026

Convatec announces interim results for the six months ended 30 June 2026

Read more Read more

15-Jul-26

Corporate

Convatec today announces two Board changes

Chief Financial Officer succession and Non-Executive Director appointment

Convatec announces two Board changes

Read more Read more

03-Jul-26

Corporate

Advanced Wound Care

Convatec completes over £24 million expansion of UK manufacturing site, strengthening supply of advanced wound care solutions

Convatec completes over £24 million expansion of UK manufacturing site, stren...

Convatec announces the completion of a multi-year expansion of over £24 million at Rhymney manufacturing site

Read more Read more

09-Jun-26

Corporate

Communities

Convatec and Lilly Foundation commit $5m to Partners In Health to improve car...

Convatec's commitment represents the next phase of its collaboration with Partners In Health

Read more Read more

04-Jun-26

Corporate

Our People

Convatec announces leadership appointments to strengthen Science, Innovation, Quality and Regulatory Affairs

Convatec announces leadership appointments to strengthen Science, Innovation,...

Convatec announces executive leadership roles for Science & Innovation and Quality & Regulatory Affairs

Read more Read more

21-May-26

Corporate

Financial Performance

AGM trading update for the four months ended 30 April 2026

AGM trading update for the four months ended 30 April 2026

AGM trading update for the four months ended 30 April 2026

Read more Read more

05-May-26

Corporate

Advanced Wound Care

Convatec’s Advanced Wound Care innovation leads the industry at EWMA 2026

Convatec’s Advanced Wound Care innovation leads the industry at European Woun...

Convatec’s Advanced Wound Care innovation leads the industry at EWMA 2026

Read more Read more

21-Apr-26

Corporate

Our People

Convatec appoints Peter Jarvis as Chief Operations Officer

Convatec appoints Peter Jarvis as Chief Operations Officer

Convatec appoints Chief Operations Officer

Read more Read more

09-Apr-26

Corporate

Convatec announces ‘Accelerate’ strategy to drive the next chapter of sustainable and profitable growth

Convatec announces ‘Accelerate’ strategy to drive the next chapter of sustai...

Convatec announces ‘Accelerate’ strategy which represents an evolution of the company’s previous FISBE strategy

Read more Read more

20-Mar-26

Corporate

Ostomy Care

Championing better support for people living with chronic conditions

Convatec’s commitment to improving the lives of people living with chronic conditions has been spotlighted in the Jou...

Read more Read more

24-Feb-26

Corporate

Financial Performance

Annual results for the year ended 31 December 2025

Strong delivery drives revenue growth, margin progress & mid-teens adjusted EPS growth

Read more Read more